- testing |
| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Nov 2025 | 14 Oct 2025 |
| Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve as per annexure enclosed As per annexure enclosed (As Per BSE Announcement Dated on: 06/11/2025) | ||
| Board Meeting | 12 Sep 2025 | 12 Sep 2025 |
| As per annexure enclosed | ||
| Board Meeting | 12 Aug 2025 | 17 Jul 2025 |
| Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve As per annexure enclosed As per annexure enclosed (As Per BSE Announcement Dated on:12.08.2025) | ||
| Board Meeting | 30 Jun 2025 | 30 Jun 2025 |
| Announcement under Regulation 30 (LODR)-Scheme of Arrangement As per annexure enclosed | ||
| Board Meeting | 30 May 2025 | 6 May 2025 |
| Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve As per annexure enclosed As per annexure enclosed (As Per BSE Announcement Dated on 30.05.2025) | ||
| Board Meeting | 10 Feb 2025 | 18 Jan 2025 |
| APOLLO HOSPITALS ENTERPRISE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 inter alia to consider and approve Further to our letter dated 24th December 2024 and pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company will be meeting on Monday February 10 2025 inter alia to consider the approval of the unaudited financial results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2024 and other related matters. Further in accordance with the Provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 (as amended) and the Companys Code of Conduct for Prevention of Insider Trading the Trading Window would continue to remain closed for Promoters Directors other connected persons and designated employees of the Company from January 1 2025 till 48 hours after the announcement of financial results i.e. upto February 12 2025. Kindly take this on record. As per annexure enclosed The Board of Directors declared an interim dividend of Rs.9/- per share (180% of face value of Rs.5/- per share) for the financial year ending 31st March 2025, on the paid up equity shares, out of the profits of the Company. The Board has fixed the record date as 15th February 2025 for the purpose of payment of Interim Dividend and the said Interim Dividend will be paid to the equity shareholders, whose names appear in the Register of Members/ Beneficial Owners of the Company as on 15th February 2025 (As Per BSE Announcement dated on 10.02.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.